Optomed PLC Total Assets
Optomed PLC total assets. Based on the latest financial reports, Optomed PLC (OPTOMED) holds total assets worth €27.19 Million EUR (≈ $31.78 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Optomed PLC (OPTOMED) cash conversion ratio for how efficiently the company converts equity into cash flow.
Total Assets of Optomed PLC (2015–2024)
Total assets of Optomed PLC from 2015 to 2024. This chart illustrates how Optomed PLC's total assets have evolved over time, based on quarterly financial data. See OPTOMED share price today for real-time trading data and today's change.
Optomed PLC - Asset Composition Analysis
Optomed PLC Total Assets Breakdown (December 2024)
Optomed PLC total assets breakdown as of December 2024. Optomed PLC's total assets of €27.19 Million consist of 49.4% current assets and 50.6% non-current assets. Explore OPTOMED working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €10.47 Million | 32.9% |
| Accounts Receivable | €3.27 Million | 10.3% |
| Inventory | €1.96 Million | 6.2% |
| Property, Plant & Equipment | €2.11 Million | 6.6% |
| Intangible Assets | €9.71 Million | 30.6% |
| Goodwill | €4.26 Million | 13.4% |
Asset Composition Trend (2015–2024)
This chart illustrates how Optomed PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Optomed PLC's current assets represent 49.4% of total assets in 2024, a decrease from 64.7% in 2015.
- Cash Position: Cash and equivalents constituted 32.9% of total assets in 2024, up from 29.6% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 43.0% of total assets, an increase from 0.0% in 2015.
- Asset Diversification: The largest asset category is cash and equivalents at 32.9% of total assets.
Optomed PLC Competitors by Total Assets
Key competitors of Optomed PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hinge Health, Inc.
NYSE:HNGE
|
USA | $827.40 Million |
|
Diagnos Inc
V:ADK
|
Canada | CA$1.17 Million |
|
Careteq Ltd
AU:CTQ
|
Australia | AU$4.44 Million |
|
FEEDBACK PLC LS-5
F:GZM0
|
Germany | €4.86 Million |
|
Kovo Healthtech Corp
V:KOVO
|
Canada | CA$6.64 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$610.14 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$92.19 Million |
Optomed PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.05 | 3.29 | 4.81 |
| Quick Ratio | 1.60 | 2.76 | 4.08 |
| Cash Ratio | 0.00 | 2.17 | 0.00 |
| Working Capital | €5.69 Million | €11.58 Million | €13.29 Million |
Optomed PLC - Advanced Valuation Insights
This section examines the relationship between Optomed PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.82 |
| Latest Market Cap to Assets Ratio | 1.02 |
| Asset Growth Rate (YoY) | 9.3% |
| Total Assets | €31.78 Million |
| Market Capitalization | $32.33 Million USD |
Valuation Analysis
Above Book Valuation: The market values Optomed PLC's assets above their book value (1.02x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Optomed PLC's assets grew by 9.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Optomed PLC (2015–2024)
The table below shows the annual total assets of Optomed PLC from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €31.78 Million ≈ $37.16 Million |
+9.29% |
| 2023-12-31 | €29.08 Million ≈ $34.00 Million |
-7.10% |
| 2022-12-31 | €31.30 Million ≈ $36.59 Million |
+7.94% |
| 2021-12-31 | €29.00 Million ≈ $33.90 Million |
-6.68% |
| 2020-12-31 | €31.07 Million ≈ $36.33 Million |
-21.55% |
| 2019-12-31 | €39.61 Million ≈ $46.31 Million |
+87.32% |
| 2018-12-31 | €21.15 Million ≈ $24.72 Million |
+113.17% |
| 2017-12-31 | €9.92 Million ≈ $11.60 Million |
-1.08% |
| 2016-12-31 | €10.03 Million ≈ $11.72 Million |
+5.33% |
| 2015-12-31 | €9.52 Million ≈ $11.13 Million |
-- |
About Optomed PLC
Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consultin… Read more